DE60333370D1 - Zur bildung von partikeln fähiges hbv-precore-protein - Google Patents

Zur bildung von partikeln fähiges hbv-precore-protein

Info

Publication number
DE60333370D1
DE60333370D1 DE60333370T DE60333370T DE60333370D1 DE 60333370 D1 DE60333370 D1 DE 60333370D1 DE 60333370 T DE60333370 T DE 60333370T DE 60333370 T DE60333370 T DE 60333370T DE 60333370 D1 DE60333370 D1 DE 60333370D1
Authority
DE
Germany
Prior art keywords
precore protein
hbv precore
particles
hbv
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60333370T
Other languages
English (en)
Inventor
Noboru Maki
Tatsuji Kimura
Shintaro Yagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Life Science Institute Inc
Original Assignee
Advanced Life Science Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Life Science Institute Inc filed Critical Advanced Life Science Institute Inc
Application granted granted Critical
Publication of DE60333370D1 publication Critical patent/DE60333370D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01DNA viruses
    • C07K14/02Hepadnaviridae, e.g. hepatitis B virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761Hepatitis B
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10123Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
DE60333370T 2002-09-06 2003-09-05 Zur bildung von partikeln fähiges hbv-precore-protein Expired - Lifetime DE60333370D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002261666 2002-09-06
PCT/JP2003/011389 WO2004022585A1 (ja) 2002-09-06 2003-09-05 粒子形成能を有するhbvプレコア蛋白質

Publications (1)

Publication Number Publication Date
DE60333370D1 true DE60333370D1 (de) 2010-08-26

Family

ID=31973137

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60333370T Expired - Lifetime DE60333370D1 (de) 2002-09-06 2003-09-05 Zur bildung von partikeln fähiges hbv-precore-protein

Country Status (12)

Country Link
US (2) US7713532B2 (de)
EP (1) EP1535927B1 (de)
JP (1) JP4459054B2 (de)
KR (1) KR101093783B1 (de)
CN (1) CN100547001C (de)
AT (1) ATE473997T1 (de)
AU (1) AU2003261977A1 (de)
CA (1) CA2497972C (de)
DE (1) DE60333370D1 (de)
ES (1) ES2344737T3 (de)
HK (1) HK1081207A1 (de)
WO (1) WO2004022585A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4386660B2 (ja) * 2003-03-25 2009-12-16 株式会社先端生命科学研究所 Hbv−rnaを含むhbv粒子
ATE493659T1 (de) * 2004-05-19 2011-01-15 Advanced Life Science Inst Inc Verfahren zum nachweis von hepatitis-b-virus
KR20070029199A (ko) * 2004-05-19 2007-03-13 멜버른 헬스 B형 간염에 대한 치료제, 예방제 및 진단제
WO2008053900A1 (fr) * 2006-10-30 2008-05-08 Advanced Life Science Institute, Inc. Procédé d'analyse immunologique à sensibilité élevée et réactif d'analyse immunologique pour le virus de l'hépatite b
KR100836745B1 (ko) * 2007-01-31 2008-06-10 (주)두비엘 Hbv 백신 및 그의 제조 방법
CN103217533B (zh) * 2012-01-21 2016-01-06 厦门大学 Anti-HBc定量检测方法及其在监控慢性乙肝患者病情发展和预测治疗疗效中的用途
CA2936092A1 (en) * 2013-01-23 2014-07-31 The Board Of Trustees Of The Leland Stanford Junior University Stabilized hepatitis b core polypeptide
WO2015133613A1 (ja) * 2014-03-07 2015-09-11 雅史 溝上 B型肝炎ウイルスレポーターベクター、b型肝炎ウイルス様粒子及びそれを用いたb型肝炎治療薬のスクリーニング方法
JP7072213B2 (ja) 2017-12-21 2022-05-20 国立研究開発法人理化学研究所 B型肝炎抗原タンパク質を標的としたイメージング用petプローブ
WO2020255425A1 (ja) * 2019-06-21 2020-12-24 国立研究開発法人理化学研究所 抗hbv剤
CN113322302B (zh) * 2021-06-02 2023-08-11 重庆医科大学 一种hbv完整病毒颗粒的免疫捕获分子检测方法
CN113777329B (zh) * 2021-09-16 2023-07-18 何秋富 一种视黄醇结合蛋白测定试剂盒及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1234040A2 (de) 1999-12-03 2002-08-28 Innogenetics N.V. Hbv sequenzen
CA2419046C (en) 2000-08-11 2007-10-02 Advanced Life Science Institute, Inc. Method for detecting or measuring hbv

Also Published As

Publication number Publication date
JP4459054B2 (ja) 2010-04-28
US8383333B2 (en) 2013-02-26
US20100285444A1 (en) 2010-11-11
JPWO2004022585A1 (ja) 2005-12-22
WO2004022585A1 (ja) 2004-03-18
AU2003261977A1 (en) 2004-03-29
CN1694898A (zh) 2005-11-09
EP1535927A1 (de) 2005-06-01
CA2497972A1 (en) 2004-03-18
CA2497972C (en) 2016-04-26
HK1081207A1 (en) 2006-05-12
CN100547001C (zh) 2009-10-07
ATE473997T1 (de) 2010-07-15
US7713532B2 (en) 2010-05-11
EP1535927A4 (de) 2006-06-21
US20060166187A1 (en) 2006-07-27
KR101093783B1 (ko) 2011-12-19
EP1535927B1 (de) 2010-07-14
KR20050053636A (ko) 2005-06-08
ES2344737T3 (es) 2010-09-06

Similar Documents

Publication Publication Date Title
HK1081207A1 (en) Hbv precore protein capable of forming particles
CY1106310T1 (el) Καθορισμος hbv αντιγονων για χρηση σε εμβολια
NO20025838L (no) Antigeniske polypeptider
UA85536C2 (en) Viral antigens
DK1294893T3 (da) Modifikation af hepatitis B-kerneantigen
DK0614465T3 (da) Hybridprotein mellem CS fra Plasmodium og HBsAg
ATE415423T1 (de) Immunisierungstherapie zur behandlung von atherosklerose
DE60320362D1 (de) Verfahren zur Herstellung von Dipeptiden
DE60307710D1 (de) Verfahren zur Herstellung von Eisenoxiden
DE60234085D1 (de) Rekombinantes super-verbindungs-interferon zur verwendung als hepatitis b oberflächenatigen und e-antigen-inhibitor
DK1949913T3 (da) Immunstimulatorisk kombination til profylakserne og behandlingen af hepatitis C
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
ATE552264T1 (de) Neue oberflächenprotein- (hbsag-) variante des hepatitis b virus
DK0750669T3 (da) Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra
WO2007008093A3 (en) A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine
ATE409705T1 (de) Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs
TW200510545A (en) HBV pre-core protein having particle-forming ability
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
ATE526035T1 (de) Tollwut-impfstoff
ATE489106T1 (de) Virusähnliche partikel, verfahren zur herstellung und immunogene zusammensetzungen
DE60330256D1 (de) Bakteriophagen-vermittelte immunisierung gegen hepatitis
ATE494555T1 (de) Verfahren in verbindung mit einer hepatitis-b- infektion
WO2002000252A3 (en) Non-human animal models of tolerance to hepatitis c virus immunogenes
TH98092B (th) วัคซีนสำหรับมาลาเรีย